Evolution of Solid Dispersion Technology: Solubility Enhancement Using Hydroxypropyl Methylcellulose Acetate...

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery
• Materials Science

Background:

• Poorly aqueous soluble active pharmaceutical ingredients (APIs) represent a significant challenge in drug discovery and development.
• Approximately 40% of compounds from combinatorial screening exhibit poor water solubility, impacting bioavailability and efficacy.
• Current strategies include particle size reduction, identifying alternate morphs, and solid dispersion technologies.

Purpose of the Study:

• To address the limitations in early-stage polymer selection for solid dispersions.
• To highlight the need for advanced preformulation tools for developing third-generation solid dispersions.
• To improve the success rate of poorly soluble drug candidates.

Main Methods:

• Review of particle size reduction techniques.
• Analysis of solid dispersion technologies, including hot-melt extrusion and spray drying.
• Discussion of polymer selection challenges, particularly with hydroxypropyl methylcellulose acetate succinate (HPMCAS).

Main Results:

• Solid dispersion technology has successfully brought numerous poorly soluble molecules to market by enhancing bioavailability.
• Existing solid dispersion approaches have evolved from eutectic mixtures to polymer-based systems.
• A critical gap exists in preformulation tools for identifying optimal polymers early in development.

Conclusions:

• There is an urgent need for the design and development of third-generation solid dispersions.
• Improved preformulation strategies are essential for efficient drug development.
• Addressing solubility challenges is crucial for meeting industry and societal needs in medicine.